Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2014 (2014), Article ID 721453, 18 pages
http://dx.doi.org/10.1155/2014/721453
Research Article

Differential Network Analyses of Alzheimer’s Disease Identify Early Events in Alzheimer’s Disease Pathology

1Department of Mathematics, University of California, Davis, CA 95616, USA
2Division of Biostatistics, School of Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA
3Department of Biology, University of Texas, San Antonio, TX 78249, USA
4Neurosciences Institute, University of Texas, San Antonio, TX 78249, USA

Received 25 January 2014; Revised 13 June 2014; Accepted 18 June 2014; Published 23 July 2014

Academic Editor: Suzanne M. de la Monte

Copyright © 2014 Jing Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. S. Liang, T. Dunckley, T. G. Beach et al., “Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set,” Physiological Genomics, vol. 33, no. 2, pp. 240–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Valla, J. D. Berndt, and F. Gonzalez-Lima, “Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration,” Journal of Neuroscience, vol. 21, no. 13, pp. 4923–4930, 2001. View at Google Scholar · View at Scopus
  3. B. A. Vogt, P. B. Crino, and L. J. Vogt, “Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding,” Cerebral Cortex, vol. 2, no. 6, pp. 526–535, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Hock, K. Heese, C. Hulette, C. Rosenberg, and U. Otten, “Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas,” Archives of Neurology, vol. 57, no. 6, pp. 846–851, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Braak and E. Braak, “Evolution of neuronal changes in the course of alzheimer's disease,” Journal of Neural Transmission, Supplement, no. 53, pp. 127–140, 1998. View at Google Scholar · View at Scopus
  6. H. Braak and E. Braak, “Neuropathological stageing of Alzheimer-related changes,” Acta Neuropathologica, vol. 82, no. 4, pp. 239–259, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Braak, E. Braak, and J. Bohl, “Staging of Alzheimer-related cortical destruction,” European Neurology, vol. 33, no. 6, pp. 403–408, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. V. G. Tusher, R. Tibshirani, and G. Chu, “Significance analysis of microarrays applied to the ionizing radiation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5116–5121, 2001. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  9. G. Dennis Jr., B. T. Sherman, D. A. Hosack et al., “DAVID: database for annotation, visualization, and integrated discovery,” Genome Biology, vol. 4, no. 5, p. P3, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Ruan and W. Zhang, “Identification and evaluation of functional modules in gene co-expression networks,” in Proceedings of the RECOMB Satellite Conferences on Systems Biology and Computational Proteomics, pp. 57–76, San Diego, Calif, USA, 2006.
  11. M. Ray and W. Zhang, “Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks,” BMC Systems Biology, vol. 4, article 136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Ray, R. Yunis, X. Chen, and D. M. Rocke, “Comparison of low and high dose ionising radiation using topological analysis of gene coexpression networks,” BMC Genomics, vol. 13, no. 1, article 190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. McDunn, K. D. Husain, A. D. Polpitiya et al., “Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram,” PLoS ONE, vol. 3, no. 2, Article ID e1564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ray, J. Ruan, and W. Zhang, “Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases,” Genome Biology, vol. 9, no. 10, article R148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ekins, Y. Nikolsky, A. Bugrim, E. Kirillov, and T. Nikolskaya, “Pathway mapping tools for analysis of high content data,” Methods in Molecular Biology, vol. 356, pp. 319–350, 2007. View at Google Scholar · View at Scopus
  16. GeneGo, http://portal.genego.com/help/p-value calculations.pdf.
  17. S. Ekins, S. Andreyev, A. Ryabov et al., “A combined approach to drug metabolism and toxicity assessment,” Drug Metabolism and Disposition, vol. 34, no. 3, pp. 495–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Canright and K. Engo-Monsen, “Spreading on networks: a topographic view,” in Proceedings of the European Conference on Complex Systems, Paris, France, 2005.
  19. P. Bonacich, “Factoring and weighting approaches to status scores and clique identification,” Journal of Mathematical Sociology, vol. 2, pp. 113–120, 1972. View at Publisher · View at Google Scholar
  20. B. Ruhnau, “Eigenvector-centrality—a node-centrality,” Social Networks, vol. 22, no. 4, pp. 357–365, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Soler-López, A. Zanzoni, R. Lluís, U. Stelzl, and P. Aloy, “Interactome mapping suggests new mechanistic details underlying Alzheimer's disease,” Genome Research, vol. 21, no. 3, pp. 364–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. T. Du, N. Schuff, D. Amend et al., “Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 71, no. 4, pp. 441–447, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. J. Carlson, B. Zhang, Z. Fang, P. S. Mischel, S. Horvath, and S. F. Nelson, “Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks,” BMC Genomics, vol. 7, article 40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. C. Oldham, S. Horvath, and D. H. Geschwind, “Conservation and evolution of gene coexpression networks in human and chimpanzee brains,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 47, pp. 17973–17978, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Oldham, G. Konopka, K. Iwamoto et al., “Functional organization of the transcriptome in human brain,” Nature Neuroscience, vol. 11, no. 11, pp. 1271–1282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. H. K. Lee, A. K. Hsu, J. Sajdak, J. Qin, and P. Pavlidis, “Coexpresion analysis of human genes across many microarray data sets,” Genome Research, vol. 14, no. 6, pp. 1085–1094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. L. Grady, M. L. Furey, P. Pietrini, B. Horwitz, and S. I. Rapoport, “Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease,” Brain, vol. 124, no. 4, pp. 739–756, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Leuba, A. Savioz, A. Vernay et al., “Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein,” Journal of Alzheimer's Disease, vol. 15, no. 1, pp. 139–151, 2008. View at Google Scholar · View at Scopus
  29. D. E. Bredesen, “Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence,” Molecular Neurodegeneration, vol. 4, no. 1, article 27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. D. J. Selkoe, “Alzheimer's disease is a synaptic failure,” Science, vol. 298, no. 5594, pp. 789–791, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. G. J. Ho, R. Drego, E. Hakimian, and E. Masliah, “Mechanisms of cell signaling and inflammation in Alzheimer's disease,” Current Drug Targets: Inflammation and Allergy, vol. 4, no. 2, pp. 247–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Arendt and M. K. Brückner, “Linking cell-cycle dysfunction in alzheimer's disease to a failure of synaptic plasticity,” Biochimica et Biophysica Acta, vol. 1772, no. 4, pp. 413–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Valla, J. D. Berndt, and F. Gonzalez-Lima, “Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration,” The Journal of Neuroscience, vol. 21, no. 13, pp. 4923–4930, 2001. View at Google Scholar · View at Scopus
  34. T.-C. Ho, S.-L. Chen, Y.-C. Yang, C.-L. Liao, H.-C. Cheng, and Y.-P. Tsao, “PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells,” Cardiovascular Research, vol. 76, no. 2, pp. 213–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Yoshida, K. Ohno-Matsui, S. Ichinose et al., “The potential role of amyloid β in the pathogenesis of age-related macular degeneration,” Journal of Clinical Investigation, vol. 115, no. 10, pp. 2793–2800, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. C. L. Maarouf, I. D. Daugs, T. A. Kokjohn et al., “Alzheimer's disease and non-demented high pathology control nonagenarians: Comparing and contrasting the biochemistry of cognitively successful aging,” PLoS ONE, vol. 6, no. 11, Article ID e27291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Cutler, E. L. Akuffo, W. M. Bodnar et al., “Proteomic identification and early validation of complement I inhibitor and pigment epithelium-derived factor: two novel biomarkers of Alzheimer's disease in human plasma,” Proteomics: Clinical Applications, vol. 2, no. 4, pp. 467–477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Maletic, M. Robinson, T. Oakes, S. Iyengar, S. G. Ball, and J. Russell, “Neurobiology of depression: an integrated view of key findings,” International Journal of Clinical Practice, vol. 61, no. 12, pp. 2030–2040, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. P. W. Landfield, E. M. Blalock, K. Chen, and N. M. Porter, “A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease,” Current Alzheimer Research, vol. 4, no. 2, pp. 205–212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Li, Y. Yao, W. Zhang, Y. Yin, G. Wu, and H. Gong, “Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice,” European Journal of Pharmacology, vol. 628, no. 1–3, pp. 108–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R. A. C. M. Boonen, P. van Tijn, and D. Zivkovic, “Wnt signaling in Alzheimer's disease: up or down, that is the question,” Ageing Research Reviews, vol. 8, no. 2, pp. 71–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. N. C. Inestrosa, L. Varela-Nallar, C. P. Grabowski, and M. Colombres, “Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target,” IUBMB Life, vol. 59, no. 4-5, pp. 316–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. G. V. De Ferrari, A. Papassotiropoulos, T. Biechele et al., “Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 22, pp. 9434–9439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Herrup, “The involvement of cell cycle events in the pathogenesis of Alzheimer's disease,” Alzheimer's Research and Therapy, vol. 2, no. 3, article 13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. P. Lopes, C. R. Oliveira, and P. Agostinho, “Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?” Current Alzheimer Research, vol. 6, no. 3, pp. 205–212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. D. J. Bonda, H. Lee, W. Kudo, X. Zhu, and M. A. Smith, “Pathological implications of cell cycle re-entry in Alzheimer disease,” Expert Reviews in Molecular Medicine, vol. 12, article e19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Gerlai, “EphB and NMDA receptors: components of synaptic plasticity coming together,” Trends in Neurosciences, vol. 25, no. 4, pp. 180–181, 2002. View at Google Scholar · View at Scopus
  48. R. Dufault, R. Schnoll, W. J. Lukiw et al., “Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children,” Behavioral and Brain Functions, vol. 5, article 44, 2009. View at Publisher · View at Google Scholar
  49. D. Costantini, V. Marasco, and A. P. Møller, “A meta-analysis of glucocorticoids as modulators of oxidative stress in vertebrates,” Journal of Comparative Physiology B, vol. 181, no. 4, pp. 447–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. T. A. Evans, A. K. Raina, A. Delacourte et al., “BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease,” International Journal of Medical Sciences, vol. 4, no. 3, pp. 140–145, 2007. View at Google Scholar · View at Scopus
  51. G. Perry, A. D. Cash, and M. A. Smith, “Alzheimer disease and oxidative stress,” Journal of Biomedicine and Biotechnology, vol. 2, no. 3, pp. 120–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. R. J. Castellani, P. I. Moreira, G. Liu et al., “Iron: the redox-active center of oxidative stress in Alzheimer disease,” Neurochemical Research, vol. 32, no. 10, pp. 1640–1645, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Gandhi and A. Y. Abramov, “Mechanism of oxidative stress in neurodegeneration,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 428010, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Murakami, Y. Moriwaki, T. Kawarabayashi et al., “PINK1, a gene product of PARK6, accumulates in α-synucleinopathy brains,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 6, pp. 653–655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Hatano, K. Sato, B. Elibol et al., “PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations,” Neurology, vol. 63, no. 8, pp. 1482–1485, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Matsuda, S. Sato, K. Shiba et al., “PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy,” Journal of Cell Biology, vol. 189, no. 2, pp. 211–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Goh, M. E. Cusick, D. Valle, B. Childs, M. Vidal, and A. Barabási, “The human disease network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 21, pp. 8685–8690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Greenblum, P. J. Turnbaugh, and E. Borenstein, “Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 2, pp. 594–599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Barrenas, S. Chavali, P. Holme, R. Mobini, and M. Benson, “Network properties of complex human disease genes identified through genome-wide association studies,” PLoS ONE, vol. 4, no. 11, Article ID e0008090, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. W. de Haan, W. M. van der Flier, H. Wang, P. F. Van Mieghem, P. Scheltens, and C. J. Stam, “Disruption of functional brain networks in alzheimer's disease: what can we learn from graph spectral analysis of resting-state magnetoencephalography?” Brain Connection, vol. 2, no. 2, pp. 45–55, 2012. View at Publisher · View at Google Scholar
  61. X. Zhao, Y. Liu, X. Wang et al., “Disrupted small-world brain networks in moderate Alzheimer's disease: a resting-state fMRI study,” PLoS ONE, vol. 7, no. 3, Article ID e33540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. He, Z. Chen, and A. Evans, “Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease,” Journal of Neuroscience, vol. 28, no. 18, pp. 4756–4766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. M. J. Stampfer, “Cardiovascular disease and Alzheimer's disease: common links,” Journal of Internal Medicine, vol. 260, no. 3, pp. 211–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Rosendorff, M. S. Beeri, and J. M. Silverman, “Cardiovascular risk factors for Alzheimer's disease,” American Journal of Geriatric Cardiology, vol. 16, no. 3, pp. 143–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Stewart, “Cardiovascular factors in Alzheimer's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 65, no. 2, pp. 143–147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler, “Increased risk of type 2 diabetes in alzheimer disease,” Diabetes, vol. 53, no. 2, pp. 474–481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. C. MacKnight, K. Rockwood, E. Awalt, and I. McDowell, “Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging,” Dementia and Geriatric Cognitive Disorders, vol. 14, no. 2, pp. 77–83, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Craft and G. S. Watson, “Insulin and neurodegenerative disease: shared and specific mechanisms,” The Lancet Neurology, vol. 3, no. 3, pp. 169–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. F. Billia, L. Hauck, F. Konecny, V. Rao, J. Shen, and T. W. Mak, “PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 23, pp. 9572–9577, 2011. View at Publisher · View at Google Scholar · View at Scopus